查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1525462

全球抗菌藥物敏感性測試市場評估：依產品類型、依應用、依最終用戶、依地區、機會、預測，2017-2031年

Antimicrobial Susceptibility Testing Market Assessment, By Product, By Type, By Application, By End-user, By Region, Opportunities and Forecast, 2017-2031F
出版日期: | 出版商: Market Xcel - Markets and Data | 英文 225 Pages | 商品交期: 3-5個工作天內

價格

2024-2031年預測期間，全球抗菌藥物敏感性測試（AST）市場規模將以年複合成長率6.07%擴大，預計將從2023年的 40.1 億美元成長到2031年的 64.3 億美元。藥敏檢測市場是臨床診斷產業的重要組成部分，在醫療保健產業中成長最快。推動市場的因素包括傳染病爆發、微生物抗藥性上升、技術進步和政府措施。

在臨床實驗室中，抗菌藥物敏感性測試（AST）用於確定哪些抗生素和其他抗菌藥物對引起疾病的特定微生物有效以及使用劑量來確定是否可以預期效果。這些測試是在用於抗菌藥物敏感性測試的各種醫療設備的幫助下進行的。 FDA 的設備和放射健康中心（CDRH）必須測試並批准 AST 設備在臨床實驗室中使用，然後才能在美國銷售。除了傳統的 AST 之外，還有許多快速診斷測試可用於識別與抗生素抗藥性細菌相關的遺傳資訊或抗藥性指標。當微生物隨著時間的推移而適應並對藥物變得無反應時，CDRH 會審查並批准這些抗菌素抗藥性或抗菌素抗藥性（AMR）測試。美國疾病管制與預防中心（CDC）估計，每年有超過 35,000 人死於抗生素抗藥性疾病，美國每年至少有 280 萬人受到感染。

傳染病率的上升是推動抗菌藥物敏感性測試市場需求的關鍵因素之一。細菌、真菌和病毒感染在世界各地呈現上升趨勢，需要更有效的抗生素治療。這些疾病的識別和治療在很大程度上依賴 AST，它顯示了不同類型的病原體如何對不同類型的抗生素做出反應。抗生素敏感性測試可幫助醫生透過確定適當的抗生素療法來制定有效的治療方案，降低抗生素抗藥性的可能性並改善患者的治療結果。隨著傳染病變得越來越普遍，新的傳染病診斷測試的開發和推廣顯著增加了對快速、準確的 AST 的需求。

本報告檢視了全球抗菌藥物敏感性測試市場，並提供了市場概述，包括依產品類型、應用、最終用戶、地區劃分的趨勢和參與市場的公司概況。

目錄

第1章 專案範圍與定義

第2章 研究方法

第3章 執行摘要

第4章 2017-2031年全球抗菌藥物敏感性測試市場展望

  • 市場規模分析與預測
  • 市佔率分析與預測
  • 2023年市場地圖分析
    • 依產品
    • 依類型
    • 依用途
    • 依最終用戶
    • 依地區

第5章 北美抗菌藥物敏感性測試市場展望，2017-2031

第6章 歐洲抗菌藥物敏感性測試市場前景，2017-2031

第7章 亞太地區抗菌藥物敏感性測試市場展望，2017-2031

第8章 南美洲抗菌藥物敏感性測試市場展望，2017-2031

第9章 中東與非洲抗菌藥物敏感性測試市場展望，2017-2031年

第10章 供需分析

第11章 進出口分析

第12章 價值鏈分析

第13章 波特五力分析

第14章 PESTLE分析

第15章 價格分析

第16章 市場動態

第17章 監理架構與創新

第18章 市場趨勢與發展

第19章 案例研究

第20章 競爭態勢

  • 頂尖市場領導者的競爭矩陣
  • 前 5 名參與公司的 SWOT 分析
  • 市場前10位主要參與者的情況
    • Biomeriux SA
    • Bio-Rad Laboratories Inc
    • HiMedia Laboratories
    • Alifax S.r.l Italy
    • Becton Dickinson and Company
    • Creative Diagnostics
    • Resistell AG
    • Danaher Corporation
    • Thermo Fisher Scientific Inc
    • Merck KGaA

第21章 策略建議

第22章 查詢及免責聲明

Product Code: MX11683

Global antimicrobial susceptibility testing market is projected to witness a CAGR of 6.07% during the forecast period 2024-2031, growing from USD 4.01 billion in 2023 to USD 6.43 billion in 2031. The antimicrobial susceptibility testing market is an important part of clinical diagnostics industry, accounting for one of the fastest growth rates in the healthcare industry. Factors are driving the market such as growing prevalence of infectious diseases, rising microbial resistance, technological advancements, and government initiatives.

In clinical laboratories, antimicrobial susceptibility tests (ASTs) are used to identify which antibiotics or other antimicrobial medicines are expected to be successful against a certain microbe causing an illness and what dose is required to be effective. These tests are performed with the help of different medical devices used for antimicrobial susceptibility tests. The FDA's Center for Devices and Radiological Health (CDRH) must examine and approve any AST devices before they may be marketed in the United States for use in clinical labs. A number of fast diagnostic tests are available to identify genetic information, or resistance indicators linked to bacteria that are resistant to antibiotics, in addition to traditional ASTs. CDRH examines and approves these tests when microorganisms adapt over time and stop responding to medications, it's known as antimicrobial resistance, or antimicrobial resistance (AMR). The Centers for Disease Control and Prevention (CDC) estimate that over 35,000 individuals lose their lives to antimicrobial-resistant illnesses each year, which account for at least 2.8 million infections in the United States annually.

The UN views AMR as a worldwide threat and issues a warning by 2050, wherein drug-resistant illnesses might claim 10 million lives annually. Antimicrobial resistance may push up to 24 million people into severe poverty by 2030, according to the United Nations estimates.

Growing Prevalence of Infectious Diseases

The growing incidence of infectious diseases is one of the key factors driving the demand for antimicrobial susceptibility testing market. The increasing rate of infections caused by bacteria, fungi, and viruses around the world has necessitated more effective treatment through antibiotics. The identification and treatment of these diseases relies heavily on AST which shows how different types of pathogens response to different kinds of antibiotics. Antibiotic susceptibility testing helps doctors to prescribe effective treatments by identifying the right antimicrobial therapy, thus reducing the likelihood of resistance to antimicrobials, improving patient outcomes. Since infectious diseases are becoming more common, the demand for fast and accurate ASTs has increased significantly due to the development and distribution of new diagnostic tests for infectious diseases.

As per HIV.gov in 2022, there were more than 39 million patients globally. Out of which, 37.5 million were adults and 1.5 million were children. WHO estimates that close to 25% of the global population i.e 1.8 billion people have tuberculosis.

Government Initiatives to Support the Global AST Market

Government funding and government initiatives are playing an important role in supporting and increasing the adoption of antimicrobial susceptibility testing kits and devices. Regulatory agencies such as the FDA (Food and Drug Administration) in the United States have issued guidance and necessary steps to help animal drugs sponsors establish defined duration of use for certain medically important antimicrobial drugs, supporting the appropriate drug usage and growing need for antimicrobial susceptibility testing. Additionally, the FDA has funded R&D initiatives through programs such as Broad Agency Announcement for supporting regulatory science and innovation in antimicrobial resistance. Government-funded partnerships, such as CARB-X, provide funding and support for early-stage projects focused towards new antibiotics, diagnostics, and other technologies to fight against drug-resistant bacteria. In March 2024, CARB-X announced its 100th project funding for addressing antibiotic resistance. CARB-X granted USD 1.06 million to Germany-based company named HIPS for the development of new class of small-molecule inhibitors.

Drug Discovery and Development is Expected to Grow at the Fastest Rate in the Forecast Period

Drug discovery and development will grow at a fast pace in the upcoming years in the global antimicrobial susceptibility testing market. Testing the antibiotic susceptibility of notable bacterial isolates is an essential function of the clinical microbiology lab. Testing ensures the susceptibility of the recommended medication for a disease and the identification of potential drug resistance in living organisms. Once the bacteria or fungi causing an individual's infection are collected in the sample culture, the susceptibility testing is carried upon it. Drug susceptibility testing can be carried out utilizing nucleic acid-based techniques, semiquantitative approaches, or qualitative methods.

At ESCMID 2024 (European Society of Clinical Microbiology and Infectious Disease), several advancements in drug resistance testing were announced, such as rapid nanomotion-based susceptibility testing and MALDI-TOF-MS could be used to identify resistance mechanisms of several deadly organisms. The conference discussed different types of novel resistance testing technologies such as machine learning models, and matrix-assisted laser desorption ionization time-of-flight mass spectrometry.

North America Dominates the Global Antimicrobial Susceptibility Testing Market

North America dominated the share of the global antimicrobial susceptibility testing market in 2023, and is expected to maintain the dominance in the forecast period. High prevalence of infectious diseases and growing burden of antibiotic resistance in countries such as the United States, Canada, and Mexico are some major drivers. The United States and Canada have advanced healthcare technologies and infrastructure couple with high healthcare spending and priority towards extensive research and development, which is facilitating the adoption of advanced antimicrobial susceptibility testing technologies. In February 2024, Visby Medical received a grant of USD 1.8 million to develop a fast and portable gonorrhoea diagnosis test that includes testing for antibiotic susceptibility. Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X), a US-based non-profit organization granted funds to a Boston-based company to develop a portable rapid polymerase chain reaction (PCR) diagnostic to identify the presence of Neisseria gonorrhoeae, a pathogen that causes gonorrhea, and its susceptibility to ciprofloxacin.

Future Market Scenario (2024-2031F)

The phenotyping of AST using flow cytometry, isothermal microcalorimetry, and digital imaging is becoming increasingly popular. Compared to standard growth-based AST, which can take 18-24 hours, can yield findings typically in 1-2 hours.

Whole genome sequencing is a genomic technique that may quickly identify genetic markers linked to antibiotic resistance. It is being investigated for AST. When contrasted with culture-based approaches, this could enable faster turnaround times.

Integrated diagnostic tools that are capable of AST and microbiological identification are becoming more common. These systems are designed to streamline the testing process and deliver fast results through data that will help with antibiotic selection.

Various regions and organizations, including the European Commission, European Food Safety Authority, European Medicines Agency, and European Centre for Disease Prevention and Control, are working to standardize and unify advancements in fast antimicrobial susceptibility testing.

Key Players Landscape and Outlook

Several medical device companies are flourishing in the antimicrobial susceptibility testing market by planning and adopting new strategies. They are complying with new strategic initiatives for antimicrobial susceptibility testing devices to increase their market presence. New agreements, contracts, acquisitions, mergers, investments, and partnerships are major ways through which they are trying to achieve higher market share.

In April 2023, Biomeriux SA and JMI labs established a six-year partnership to work together on projects aimed at assessing the effectiveness and expanding the potential of rapid and innovative microbiological diagnostics as crucial instruments in the fight against antibiotic resistance.

Table of Contents

1. Project Scope and Definitions

2. Research Methodology

3. Executive Summary

4. Global Antimicrobial Susceptibility Testing Market Outlook, 2017-2031F

  • 4.1. Market Size Analysis & Forecast
    • 4.1.1. By Value
    • 4.1.2. By Volume
  • 4.2. Market Share Analysis & Forecast
    • 4.2.1. By Product
      • 4.2.1.1. Manual Antimicrobial Susceptibility Testing Product
      • 4.2.1.2. Automated Laboratory Instruments
      • 4.2.1.3. Culture and Growth Media
      • 4.2.1.4. Consumables
    • 4.2.2. By Type
      • 4.2.2.1. Antibacterial Susceptibility Testing
      • 4.2.2.2. Antifungal Susceptibility Testing
      • 4.2.2.3. Antiparasitic Susceptibility Testing
      • 4.2.2.4. Other Susceptibility Testing
    • 4.2.3. By Application
      • 4.2.3.1. Clinical Diagnostics
      • 4.2.3.2. Drug Discovery and Development
      • 4.2.3.3. Epidemiology
      • 4.2.3.4. Others
    • 4.2.4. By End-user
      • 4.2.4.1. Hospitals
      • 4.2.4.2. Diagnostic Centers
      • 4.2.4.3. Pharmaceutical and Biotechnology Companies
      • 4.2.4.4. Clinical Research Organizations
      • 4.2.4.5. Others
    • 4.2.5. By Region
      • 4.2.5.1. North America
      • 4.2.5.2. Europe
      • 4.2.5.3. Asia-Pacific
      • 4.2.5.4. South America
      • 4.2.5.5. Middle East and Africa
    • 4.2.6. By Company Market Share Analysis (Top 5 Companies and Others - By Value, 2023)
  • 4.3. Market Map Analysis, 2023
    • 4.3.1. By Product
    • 4.3.2. By Type
    • 4.3.3. By Application
    • 4.3.4. By End-user
    • 4.3.5. By Region

5. North America Antimicrobial Susceptibility Testing Market Outlook, 2017-2031F*

  • 5.1. Market Size Analysis & Forecast
    • 5.1.1. By Value
    • 5.1.2. By Volume
  • 5.2. Market Share Analysis & Forecast
    • 5.2.1. By Product
      • 5.2.1.1. Manual Antimicrobial Susceptibility Testing Product
      • 5.2.1.2. Automated Laboratory Instruments
      • 5.2.1.3. Culture and Growth Media
      • 5.2.1.4. Consumables
    • 5.2.2. By Type
      • 5.2.2.1. Antibacterial Susceptibility Testing
      • 5.2.2.2. Antifungal Susceptibility Testing
      • 5.2.2.3. Antiparasitic Susceptibility Testing
      • 5.2.2.4. Other Susceptibility Testing
    • 5.2.3. By Application
      • 5.2.3.1. Clinical Diagnostics
      • 5.2.3.2. Drug Discovery and Development
      • 5.2.3.3. Epidemiology
      • 5.2.3.4. Others
    • 5.2.4. By End-user
      • 5.2.4.1. Hospitals
      • 5.2.4.2. Diagnostic Centers
      • 5.2.4.3. Pharmaceutical and Biotechnology Companies
      • 5.2.4.4. Clinical Research Organizations
      • 5.2.4.5. Others
    • 5.2.5. By Country Share
      • 5.2.5.1. United States
      • 5.2.5.2. Canada
      • 5.2.5.3. Mexico
  • 5.3. Country Market Assessment
    • 5.3.1. United States Antimicrobial Susceptibility Testing Market Outlook, 2017-2031F*
      • 5.3.1.1. Market Size Analysis & Forecast
        • 5.3.1.1.1. By Value
        • 5.3.1.1.2. By Volume
      • 5.3.1.2. Market Share Analysis & Forecast
        • 5.3.1.2.1. By Product
          • 5.3.1.2.1.1. Manual Antimicrobial Susceptibility Testing Product
          • 5.3.1.2.1.2. Automated Laboratory Instruments
          • 5.3.1.2.1.3. Culture and Growth Media
          • 5.3.1.2.1.4. Consumables
        • 5.3.1.2.2. By Type
          • 5.3.1.2.2.1. Antibacterial Susceptibility Testing
          • 5.3.1.2.2.2. Antifungal Susceptibility Testing
          • 5.3.1.2.2.3. Antiparasitic Susceptibility Testing
          • 5.3.1.2.2.4. Other Susceptibility Testing
        • 5.3.1.2.3. By Application
          • 5.3.1.2.3.1. Clinical Diagnostics
          • 5.3.1.2.3.2. Drug Discovery and Development
          • 5.3.1.2.3.3. Epidemiology
          • 5.3.1.2.3.4. Others
        • 5.3.1.2.4. By End-user
          • 5.3.1.2.4.1. Hospitals
          • 5.3.1.2.4.2. Diagnostic Centers
          • 5.3.1.2.4.3. Pharmaceutical and Biotechnology Companies
          • 5.3.1.2.4.4. Clinical Research Organizations
          • 5.3.1.2.4.5. Others
    • 5.3.2. Canada
    • 5.3.3. Mexico

All segments will be provided for all regions and countries covered

6. Europe Antimicrobial Susceptibility Testing Market Outlook, 2017-2031F

  • 6.1. Germany
  • 6.2. France
  • 6.3. Italy
  • 6.4. United Kingdom
  • 6.5. Russia
  • 6.6. Netherlands
  • 6.7. Spain
  • 6.8. Turkey
  • 6.9. Poland

7. Asia-Pacific Antimicrobial Susceptibility Testing Market Outlook, 2017-2031F

  • 7.1. India
  • 7.2. China
  • 7.3. Japan
  • 7.4. Australia
  • 7.5. Vietnam
  • 7.6. South Korea
  • 7.7. Indonesia
  • 7.8. Philippines

8. South America Antimicrobial Susceptibility Testing Market Outlook, 2017-2031F

  • 8.1. Brazil
  • 8.2. Argentina

9. Middle East and Africa Antimicrobial Susceptibility Testing Market Outlook, 2017-2031F

  • 9.1. Saudi Arabia
  • 9.2. UAE
  • 9.3. South Africa

10. Demand Supply Analysis

11. Import and Export Analysis

12. Value Chain Analysis

13. Porter's Five Forces Analysis

14. PESTLE Analysis

15. Pricing Analysis

16. Market Dynamics

  • 16.1. Market Drivers
  • 16.2. Market Challenges

17. Regulatory Framework and Innovation

  • 17.1. Clinical Trials
  • 17.2. Patent Landscape
  • 17.3. Regulatory Approvals
  • 17.4. Innovations/Emerging Technologies

18. Market Trends and Developments

19. Case Studies

20. Competitive Landscape

  • 20.1. Competition Matrix of Top 5 Market Leaders
  • 20.2. SWOT Analysis for Top 5 Players
  • 20.3. Key Players Landscape for Top 10 Market Players
    • 20.3.1. Biomeriux SA
      • 20.3.1.1. Company Details
      • 20.3.1.2. Key Management Personnel
      • 20.3.1.3. Products and Services
      • 20.3.1.4. Financials (As Reported)
      • 20.3.1.5. Key Market Focus and Geographical Presence
      • 20.3.1.6. Recent Developments/Collaborations/Partnerships/Mergers and Acquisition
    • 20.3.2. Bio-Rad Laboratories Inc
    • 20.3.3. HiMedia Laboratories
    • 20.3.4. Alifax S.r.l Italy
    • 20.3.5. Becton Dickinson and Company
    • 20.3.6. Creative Diagnostics
    • 20.3.7. Resistell AG
    • 20.3.8. Danaher Corporation
    • 20.3.9. Thermo Fisher Scientific Inc
    • 20.3.10. Merck KGaA

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

21. Strategic Recommendations

22. About Us and Disclaimer

List of Tables

  • Table 1. Pricing Analysis of Products from Key Players
  • Table 2. Competition Matrix of Top 5 Market Leaders
  • Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
  • Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

  • Figure 1. Global Antimicrobial Susceptibility Testing Market, By Value, In USD Billion, 2017-2031F
  • Figure 2. Global Antimicrobial Susceptibility Testing Market, By Volume, In Million Units, 2017-2031F
  • Figure 3. Global Antimicrobial Susceptibility Testing Market Share (%), By Product, 2017-2031F
  • Figure 4. Global Antimicrobial Susceptibility Testing Market Share (%), By Type, 2017-2031F
  • Figure 5. Global Antimicrobial Susceptibility Testing Market Share (%), By Application, 2017-2031F
  • Figure 6. Global Antimicrobial Susceptibility Testing Market Share (%), By End-user, 2017-2031F
  • Figure 7. Global Antimicrobial Susceptibility Testing Market Share (%), By Region, 2017-2031F
  • Figure 8. North America Antimicrobial Susceptibility Testing Market, By Value, In USD Billion, 2017-2031F
  • Figure 9. North America Antimicrobial Susceptibility Testing Market, By Volume, In Million Units, 2017-2031F
  • Figure 10. North America Antimicrobial Susceptibility Testing Market Share (%), By Product, 2017-2031F
  • Figure 11. North America Antimicrobial Susceptibility Testing Market Share (%), By Type, 2017-2031F
  • Figure 12. North America Antimicrobial Susceptibility Testing Market Share (%), By Application, 2017-2031F
  • Figure 13. North America Antimicrobial Susceptibility Testing Market Share (%), By End-user, 2017-2031F
  • Figure 14. North America Antimicrobial Susceptibility Testing Market Share (%), By Country, 2017-2031F
  • Figure 15. United States Antimicrobial Susceptibility Testing Market, By Value, In USD Billion, 2017-2031F
  • Figure 16. United States Antimicrobial Susceptibility Testing Market, By Volume, In Million Units, 2017-2031F
  • Figure 17. United States Antimicrobial Susceptibility Testing Market Share (%), By Product, 2017-2031F
  • Figure 18. United States Antimicrobial Susceptibility Testing Market Share (%), By Type, 2017-2031F
  • Figure 19. United States Antimicrobial Susceptibility Testing Market Share (%), By Application, 2017-2031F
  • Figure 20. United States Antimicrobial Susceptibility Testing Market Share (%), By End-user, 2017-2031F
  • Figure 21. Canada Antimicrobial Susceptibility Testing Market, By Value, In USD Billion, 2017-2031F
  • Figure 22. Canada Antimicrobial Susceptibility Testing Market, By Volume, In Million Units, 2017-2031F
  • Figure 23. Canada Antimicrobial Susceptibility Testing Market Share (%), By Product, 2017-2031F
  • Figure 24. Canada Antimicrobial Susceptibility Testing Market Share (%), By Type, 2017-2031F
  • Figure 25. Canada Antimicrobial Susceptibility Testing Market Share (%), By Application, 2017-2031F
  • Figure 26. Canada Antimicrobial Susceptibility Testing Market Share (%), By End-user, 2017-2031F
  • Figure 27. Mexico Antimicrobial Susceptibility Testing Market, By Value, In USD Billion, 2017-2031F
  • Figure 28. Mexico Antimicrobial Susceptibility Testing Market, By Volume, In Million Units, 2017-2031F
  • Figure 29. Mexico Antimicrobial Susceptibility Testing Market Share (%), By Product, 2017-2031F
  • Figure 30. Mexico Antimicrobial Susceptibility Testing Market Share (%), By Type, 2017-2031F
  • Figure 31. Mexico Antimicrobial Susceptibility Testing Market Share (%), By Application, 2017-2031F
  • Figure 32. Mexico Antimicrobial Susceptibility Testing Market Share (%), By End-user, 2017-2031F
  • Figure 33. Europe Antimicrobial Susceptibility Testing Market, By Value, In USD Billion, 2017-2031F
  • Figure 34. Europe Antimicrobial Susceptibility Testing Market, By Volume, In Million Units, 2017-2031F
  • Figure 35. Europe Antimicrobial Susceptibility Testing Market Share (%), By Product, 2017-2031F
  • Figure 36. Europe Antimicrobial Susceptibility Testing Market Share (%), By Type, 2017-2031F
  • Figure 37. Europe Antimicrobial Susceptibility Testing Market Share (%), By Application, 2017-2031F
  • Figure 38. Europe Antimicrobial Susceptibility Testing Market Share (%), By End-user, 2017-2031F
  • Figure 39. Europe Antimicrobial Susceptibility Testing Market Share (%), By Country, 2017-2031F
  • Figure 40. Germany Antimicrobial Susceptibility Testing Market, By Value, In USD Billion, 2017-2031F
  • Figure 41. Germany Antimicrobial Susceptibility Testing Market, By Volume, In Million Units, 2017-2031F
  • Figure 42. Germany Antimicrobial Susceptibility Testing Market Share (%), By Product, 2017-2031F
  • Figure 43. Germany Antimicrobial Susceptibility Testing Market Share (%), By Type, 2017-2031F
  • Figure 44. Germany Antimicrobial Susceptibility Testing Market Share (%), By Application, 2017-2031F
  • Figure 45. Germany Antimicrobial Susceptibility Testing Market Share (%), By End-user, 2017-2031F
  • Figure 46. France Antimicrobial Susceptibility Testing Market, By Value, In USD Billion, 2017-2031F
  • Figure 47. France Antimicrobial Susceptibility Testing Market, By Volume, In Million Units, 2017-2031F
  • Figure 48. France Antimicrobial Susceptibility Testing Market Share (%), By Product, 2017-2031F
  • Figure 49. France Antimicrobial Susceptibility Testing Market Share (%), By Type, 2017-2031F
  • Figure 50. France Antimicrobial Susceptibility Testing Market Share (%), By Application, 2017-2031F
  • Figure 51. France Antimicrobial Susceptibility Testing Market Share (%), By End-user, 2017-2031F
  • Figure 52. Italy Antimicrobial Susceptibility Testing Market, By Value, In USD Billion, 2017-2031F
  • Figure 53. Italy Antimicrobial Susceptibility Testing Market, By Volume, In Million Units, 2017-2031F
  • Figure 54. Italy Antimicrobial Susceptibility Testing Market Share (%), By Product, 2017-2031F
  • Figure 55. Italy Antimicrobial Susceptibility Testing Market Share (%), By Type, 2017-2031F
  • Figure 56. Italy Antimicrobial Susceptibility Testing Market Share (%), By Application, 2017-2031F
  • Figure 57. Italy Antimicrobial Susceptibility Testing Market Share (%), By End-user, 2017-2031F
  • Figure 58. United Kingdom Antimicrobial Susceptibility Testing Market, By Value, In USD Billion, 2017-2031F
  • Figure 59. United Kingdom Antimicrobial Susceptibility Testing Market, By Volume, In Million Units, 2017-2031F
  • Figure 60. United Kingdom Antimicrobial Susceptibility Testing Market Share (%), By Product, 2017-2031F
  • Figure 61. United Kingdom Antimicrobial Susceptibility Testing Market Share (%), By Type, 2017-2031F
  • Figure 62. United Kingdom Antimicrobial Susceptibility Testing Market Share (%), By Application, 2017-2031F
  • Figure 63. United Kingdom Antimicrobial Susceptibility Testing Market Share (%), By End-user, 2017-2031F
  • Figure 64. Russia Antimicrobial Susceptibility Testing Market, By Value, In USD Billion, 2017-2031F
  • Figure 65. Russia Antimicrobial Susceptibility Testing Market, By Volume, In Million Units, 2017-2031F
  • Figure 66. Russia Antimicrobial Susceptibility Testing Market Share (%), By Product, 2017-2031F
  • Figure 67. Russia Antimicrobial Susceptibility Testing Market Share (%), By Type, 2017-2031F
  • Figure 68. Russia Antimicrobial Susceptibility Testing Market Share (%), By Application, 2017-2031F
  • Figure 69. Russia Antimicrobial Susceptibility Testing Market Share (%), By End-user, 2017-2031F
  • Figure 70. Netherlands Antimicrobial Susceptibility Testing Market, By Value, In USD Billion, 2017-2031F
  • Figure 71. Netherlands Antimicrobial Susceptibility Testing Market, By Volume, In Million Units, 2017-2031F
  • Figure 72. Netherlands Antimicrobial Susceptibility Testing Market Share (%), By Product, 2017-2031F
  • Figure 73. Netherlands Antimicrobial Susceptibility Testing Market Share (%), By Type, 2017-2031F
  • Figure 74. Netherlands Antimicrobial Susceptibility Testing Market Share (%), By Application, 2017-2031F
  • Figure 75. Netherlands Antimicrobial Susceptibility Testing Market Share (%), By End-user, 2017-2031F
  • Figure 76. Spain Antimicrobial Susceptibility Testing Market, By Value, In USD Billion, 2017-2031F
  • Figure 77. Spain Antimicrobial Susceptibility Testing Market, By Volume, In Million Units, 2017-2031F
  • Figure 78. Spain Antimicrobial Susceptibility Testing Market Share (%), By Product, 2017-2031F
  • Figure 79. Spain Antimicrobial Susceptibility Testing Market Share (%), By Type, 2017-2031F
  • Figure 80. Spain Antimicrobial Susceptibility Testing Market Share (%), By Application, 2017-2031F
  • Figure 81. Spain Antimicrobial Susceptibility Testing Market Share (%), By End-user, 2017-2031F
  • Figure 82. Turkey Antimicrobial Susceptibility Testing Market, By Value, In USD Billion, 2017-2031F
  • Figure 83. Turkey Antimicrobial Susceptibility Testing Market, By Volume, In Million Units, 2017-2031F
  • Figure 84. Turkey Antimicrobial Susceptibility Testing Market Share (%), By Product, 2017-2031F
  • Figure 85. Turkey Antimicrobial Susceptibility Testing Market Share (%), By Type, 2017-2031F
  • Figure 86. Turkey Antimicrobial Susceptibility Testing Market Share (%), By Application, 2017-2031F
  • Figure 87. Turkey Antimicrobial Susceptibility Testing Market Share (%), By End-user, 2017-2031F
  • Figure 88. Poland Antimicrobial Susceptibility Testing Market, By Value, In USD Billion, 2017-2031F
  • Figure 89. Poland Antimicrobial Susceptibility Testing Market, By Volume, In Million Units, 2017-2031F
  • Figure 90. Poland Antimicrobial Susceptibility Testing Market Share (%), By Product, 2017-2031F
  • Figure 91. Poland Antimicrobial Susceptibility Testing Market Share (%), By Type, 2017-2031F
  • Figure 92. Poland Antimicrobial Susceptibility Testing Market Share (%), By Application, 2017-2031F
  • Figure 93. Poland Antimicrobial Susceptibility Testing Market Share (%), By End-user, 2017-2031F
  • Figure 94. South America Antimicrobial Susceptibility Testing Market, By Value, In USD Billion, 2017-2031F
  • Figure 95. South America Antimicrobial Susceptibility Testing Market, By Volume, In Million Units, 2017-2031F
  • Figure 96. South America Antimicrobial Susceptibility Testing Market Share (%), By Product, 2017-2031F
  • Figure 97. South America Antimicrobial Susceptibility Testing Market Share (%), By Type, 2017-2031F
  • Figure 98. South America Antimicrobial Susceptibility Testing Market Share (%), By Application, 2017-2031F
  • Figure 99. South America Antimicrobial Susceptibility Testing Market Share (%), By End-user, 2017-2031F
  • Figure 100. South America Antimicrobial Susceptibility Testing Market Share (%), By Country, 2017-2031F
  • Figure 101. Brazil Antimicrobial Susceptibility Testing Market, By Value, In USD Billion, 2017-2031F
  • Figure 102. Brazil Antimicrobial Susceptibility Testing Market, By Volume, In Million Units, 2017-2031F
  • Figure 103. Brazil Antimicrobial Susceptibility Testing Market Share (%), By Product, 2017-2031F
  • Figure 104. Brazil Antimicrobial Susceptibility Testing Market Share (%), By Type, 2017-2031F
  • Figure 105. Brazil Antimicrobial Susceptibility Testing Market Share (%), By Application, 2017-2031F
  • Figure 106. Brazil Antimicrobial Susceptibility Testing Market Share (%), By End-user, 2017-2031F
  • Figure 107. Argentina Antimicrobial Susceptibility Testing Market, By Value, In USD Billion, 2017-2031F
  • Figure 108. Argentina Antimicrobial Susceptibility Testing Market, By Volume, In Million Units, 2017-2031F
  • Figure 109. Argentina Antimicrobial Susceptibility Testing Market Share (%), By Product, 2017-2031F
  • Figure 110. Argentina Antimicrobial Susceptibility Testing Market Share (%), By Type, 2017-2031F
  • Figure 111. Argentina Antimicrobial Susceptibility Testing Market Share (%), By Application, 2017-2031F
  • Figure 112. Argentina Antimicrobial Susceptibility Testing Market Share (%), By End-user, 2017-2031F
  • Figure 113. Asia-Pacific Antimicrobial Susceptibility Testing Market, By Value, In USD Billion, 2017-2031F
  • Figure 114. Asia-Pacific Antimicrobial Susceptibility Testing Market, By Volume, In Million Units, 2017-2031F
  • Figure 115. Asia-Pacific Antimicrobial Susceptibility Testing Market Share (%), By Product, 2017-2031F
  • Figure 116. Asia-Pacific Antimicrobial Susceptibility Testing Market Share (%), By Type, 2017-2031F
  • Figure 117. Asia-Pacific Antimicrobial Susceptibility Testing Market Share (%), By Application, 2017-2031F
  • Figure 118. Asia-Pacific Antimicrobial Susceptibility Testing Market Share (%), By End-user, 2017-2031F
  • Figure 119. Asia-Pacific Antimicrobial Susceptibility Testing Market Share (%), By Country, 2017-2031F
  • Figure 120. India Antimicrobial Susceptibility Testing Market, By Value, In USD Billion, 2017-2031F
  • Figure 121. India Antimicrobial Susceptibility Testing Market, By Volume, In Million Units, 2017-2031F
  • Figure 122. India Antimicrobial Susceptibility Testing Market Share (%), By Product, 2017-2031F
  • Figure 123. India Antimicrobial Susceptibility Testing Market Share (%), By Type, 2017-2031F
  • Figure 124. India Antimicrobial Susceptibility Testing Market Share (%), By Application, 2017-2031F
  • Figure 125. India Antimicrobial Susceptibility Testing Market Share (%), By End-user, 2017-2031F
  • Figure 126. China Antimicrobial Susceptibility Testing Market, By Value, In USD Billion, 2017-2031F
  • Figure 127. China Antimicrobial Susceptibility Testing Market, By Volume, In Million Units, 2017-2031F
  • Figure 128. China Antimicrobial Susceptibility Testing Market Share (%), By Product, 2017-2031F
  • Figure 129. China Antimicrobial Susceptibility Testing Market Share (%), By Type, 2017-2031F
  • Figure 130. China Antimicrobial Susceptibility Testing Market Share (%), By Application, 2017-2031F
  • Figure 131. China Antimicrobial Susceptibility Testing Market Share (%), By End-user, 2017-2031F
  • Figure 132. Japan Antimicrobial Susceptibility Testing Market, By Value, In USD Billion, 2017-2031F
  • Figure 133. Japan Antimicrobial Susceptibility Testing Market, By Volume, In Million Units, 2017-2031F
  • Figure 134. Japan Antimicrobial Susceptibility Testing Market Share (%), By Product, 2017-2031F
  • Figure 135. Japan Antimicrobial Susceptibility Testing Market Share (%), By Type, 2017-2031F
  • Figure 136. Japan Antimicrobial Susceptibility Testing Market Share (%), By Application, 2017-2031F
  • Figure 137. Japan Antimicrobial Susceptibility Testing Market Share (%), By End-user, 2017-2031F
  • Figure 138. Australia Antimicrobial Susceptibility Testing Market, By Value, In USD Billion, 2017-2031F
  • Figure 139. Australia Antimicrobial Susceptibility Testing Market, By Volume, In Million Units, 2017-2031F
  • Figure 140. Australia Antimicrobial Susceptibility Testing Market Share (%), By Product, 2017-2031F
  • Figure 141. Australia Antimicrobial Susceptibility Testing Market Share (%), By Type, 2017-2031F
  • Figure 142. Australia Antimicrobial Susceptibility Testing Market Share (%), By Application, 2017-2031F
  • Figure 143. Australia Antimicrobial Susceptibility Testing Market Share (%), By End-user, 2017-2031F
  • Figure 144. Vietnam Antimicrobial Susceptibility Testing Market, By Value, In USD Billion, 2017-2031F
  • Figure 145. Vietnam Antimicrobial Susceptibility Testing Market, By Volume, In Million Units, 2017-2031F
  • Figure 146. Vietnam Antimicrobial Susceptibility Testing Market Share (%), By Product, 2017-2031F
  • Figure 147. Vietnam Antimicrobial Susceptibility Testing Market Share (%), By Type, 2017-2031F
  • Figure 148. Vietnam Antimicrobial Susceptibility Testing Market Share (%), By Application, 2017-2031F
  • Figure 149. Vietnam Antimicrobial Susceptibility Testing Market Share (%), By End-user, 2017-2031F
  • Figure 150. South Korea Antimicrobial Susceptibility Testing Market, By Value, In USD Billion, 2017-2031F
  • Figure 151. South Korea Antimicrobial Susceptibility Testing Market, By Volume, In Million Units, 2017-2031F
  • Figure 152. South Korea Antimicrobial Susceptibility Testing Market Share (%), By Product, 2017-2031F
  • Figure 153. South Korea Antimicrobial Susceptibility Testing Market Share (%), By Type, 2017-2031F
  • Figure 154. South Korea Antimicrobial Susceptibility Testing Market Share (%), By Application, 2017-2031F
  • Figure 155. South Korea Antimicrobial Susceptibility Testing Market Share (%), By End-user, 2017-2031F
  • Figure 156. Indonesia Antimicrobial Susceptibility Testing Market, By Value, In USD Billion, 2017-2031F
  • Figure 157. Indonesia Antimicrobial Susceptibility Testing Market, By Volume, In Million Units, 2017-2031F
  • Figure 158. Indonesia Antimicrobial Susceptibility Testing Market Share (%), By Product, 2017-2031F
  • Figure 159. Indonesia Antimicrobial Susceptibility Testing Market Share (%), By Type, 2017-2031F
  • Figure 160. Indonesia Antimicrobial Susceptibility Testing Market Share (%), By Application, 2017-2031F
  • Figure 161. Indonesia Antimicrobial Susceptibility Testing Market Share (%), By End-user, 2017-2031F
  • Figure 162. Philippines Antimicrobial Susceptibility Testing Market, By Value, In USD Billion, 2017-2031F
  • Figure 163. Philippines Antimicrobial Susceptibility Testing Market, By Volume, In Million Units, 2017-2031F
  • Figure 164. Philippines Antimicrobial Susceptibility Testing Market Share (%), By Product, 2017-2031F
  • Figure 165. Philippines Antimicrobial Susceptibility Testing Market Share (%), By Type, 2017-2031F
  • Figure 166. Philippines Antimicrobial Susceptibility Testing Market Share (%), By Application, 2017-2031F
  • Figure 167. Philippines Antimicrobial Susceptibility Testing Market Share (%), By End-user, 2017-2031F
  • Figure 168. Middle East & Africa Antimicrobial Susceptibility Testing Market, By Value, In USD Billion, 2017-2031F
  • Figure 169. Middle East & Africa Antimicrobial Susceptibility Testing Market, By Volume, In Million Units, 2017-2031F
  • Figure 170. Middle East & Africa Antimicrobial Susceptibility Testing Market Share (%), By Product, 2017-2031F
  • Figure 171. Middle East & Africa Antimicrobial Susceptibility Testing Market Share (%), By Type, 2017-2031F
  • Figure 172. Middle East & Africa Antimicrobial Susceptibility Testing Market Share (%), By Application, 2017-2031F
  • Figure 173. Middle East & Africa Antimicrobial Susceptibility Testing Market Share (%), By End-user, 2017-2031F
  • Figure 174. Middle East & Africa Antimicrobial Susceptibility Testing Market Share (%), By Country, 2017-2031F
  • Figure 175. Saudi Arabia Antimicrobial Susceptibility Testing Market, By Value, In USD Billion, 2017-2031F
  • Figure 176. Saudi Arabia Antimicrobial Susceptibility Testing Market, By Volume, In Million Units, 2017-2031F
  • Figure 177. Saudi Arabia Antimicrobial Susceptibility Testing Market Share (%), By Product, 2017-2031F
  • Figure 178. Saudi Arabia Antimicrobial Susceptibility Testing Market Share (%), By Type, 2017-2031F
  • Figure 179. Saudi Arabia Antimicrobial Susceptibility Testing Market Share (%), By Application, 2017-2031F
  • Figure 180. Saudi Arabia Antimicrobial Susceptibility Testing Market Share (%), By End-user, 2017-2031F
  • Figure 181. UAE Antimicrobial Susceptibility Testing Market, By Value, In USD Billion, 2017-2031F
  • Figure 182. UAE Antimicrobial Susceptibility Testing Market, By Volume, In Million Units, 2017-2031F
  • Figure 183. UAE Antimicrobial Susceptibility Testing Market Share (%), By Product, 2017-2031F
  • Figure 184. UAE Antimicrobial Susceptibility Testing Market Share (%), By Type, 2017-2031F
  • Figure 185. UAE Antimicrobial Susceptibility Testing Market Share (%), By Application, 2017-2031F
  • Figure 186. UAE Antimicrobial Susceptibility Testing Market Share (%), By End-user, 2017-2031F
  • Figure 187. South Africa Antimicrobial Susceptibility Testing Market, By Value, In USD Billion, 2017-2031F
  • Figure 188. South Africa Antimicrobial Susceptibility Testing Market, By Volume, In Million Units, 2017-2031F
  • Figure 189. South Africa Antimicrobial Susceptibility Testing Market Share (%), By Product, 2017-2031F
  • Figure 190. South Africa Antimicrobial Susceptibility Testing Market Share (%), By Type, 2017-2031F
  • Figure 191. South Africa Antimicrobial Susceptibility Testing Market Share (%), By Application, 2017-2031F
  • Figure 192. South Africa Antimicrobial Susceptibility Testing Market Share (%), By End-user, 2017-2031F
  • Figure 193. By Product Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 194. By Type Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 195. By Application Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 196. By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 197. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2023